BHRT vs traditional HRT: which should I ask for and where?

Short answer

• If you want the safest, best‑studied option, ask first about evidence‑based (traditional) HRT using FDA‑approved products (estradiol ± a progestogen when you still have a uterus).
• BHRT (compounded “bioidentical” hormones) can be considered if you need a dose or formulation that’s not commercially available or you’ve had problems with standard products — but it’s less regulated and not proven safer or more effective.

Why (brief)

• Traditional HRT: FDA‑approved products (brands and formulations) have known dosing, quality control, and safety data. Examples: estradiol patches (Vivelle‑Dot, Climara), estradiol gels (Divigel, EstroGel), oral estradiol (Estrace), vaginal estrogens (Vagifem, Estring). For progestogen: micronized progesterone (Prometrium) is a bioidentical, FDA‑approved option used to protect the uterus.
• BHRT / compounded hormones: marketed as “natural” and individualized; may be useful for unusual dosing or preparations. But compounded products are not FDA‑reviewed for consistency or purity, variable between pharmacies, and major menopause societies do not recommend them as first‑line for routine use.

Which to ask your clinician for

• Start by discussing goals and risks with a clinician experienced in menopause. If you have no major contraindications and want symptom control, ask about:
  • Transdermal estradiol (patch or gel) if you want stable blood levels and lower VTE risk (brands above).
  • Add micronized progesterone (Prometrium) if you still have a uterus.
  • Vaginal estrogen (Vagifem, Estring) for local genitourinary symptoms if systemic therapy isn’t needed.
• Consider BHRT only after discussing pros/cons and only via a prescriber who knows menopause care and uses an accredited compounding pharmacy.

Where to go / who to ask

• Look for a NAMS‑certified menopause practitioner (North American Menopause Society) — they specialize in up‑to‑date HRT management.
• Good places to get thorough evaluation: academic menopause clinics (Mayo Clinic Menopause Clinic, Cleveland Clinic Women’s Health, Johns Hopkins Menopause Program) or a board‑certified gynecologist/endocrinologist with menopause experience.
• If you pursue compounded BHRT, use a reputable, accredited compounding pharmacy (look for PCAB/ACHC accreditation and certificates of analysis). Well‑known compounding pharmacies used by many clinicians include Wedgewood Pharmacy, Belmar Pharmacy, and Empower Pharmacy — but verify accreditation and quality documentation yourself.

Practical points to discuss with the clinician

• Your symptoms, age, time since menopause, personal/family history of breast cancer, blood clots, heart disease, stroke.
• Whether you still have a uterus (determines need for progestogen).
• Route preference (patch/gel/oral/vaginal) — transdermal is often preferred if clot risk is a concern.
• Safety, duration, monitoring plan, and non‑hormonal alternatives (SSRIs/SNRIs, gabapentin, topical vaginal estrogen).
• If considering BHRT, insist on lab test validity (avoid saliva tests as sole basis), pharmacy accreditation, and a clear plan for follow‑up.

If you’d like, tell me: your age, how long since menopause or last period, main symptoms, and any major health history (clotting, breast cancer, heart disease). I can suggest questions to bring to a clinician and which specific formulations are most likely to fit your situation.